Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maria Antonietta Blasi
Pembrolizumab as First-Line Treatment for Metastatic Uveal Melanoma
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
Frontiers in Oncology
Cancer Research
Oncology
Related publications
Pembrolizumab-Induced Sarcoid-Like Reactions During Treatment of Metastatic Melanoma
Radiology
Nuclear Medicine
Radiology
Imaging
Nanoparticles for Uveal Melanoma Treatment
Cutaneous CD56 + T-Cell Lymphoma Developing During Pembrolizumab Treatment for Metastatic Melanoma
JAAD Case Reports
Dermatology
Nestin Expression in Primary and Metastatic Uveal Melanoma - Possible Biomarker for High-Risk Uveal Melanoma
Acta Ophthalmologica
Medicine
Ophthalmology
Pcn34 - Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-Squamous NSCLC – A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Verification of EZH2 as a Druggable Target in Metastatic Uveal Melanoma
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Cost Effectiveness of PD-L1-Based Test-And-Treat Strategy With Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong
PharmacoEconomics - Open
Health Policy
Pharmacology
Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Network Meta-Analysis
Immunotherapy
Oncology
Allergy
Immunology
iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors
PLoS ONE
Multidisciplinary
